Super Vesicle
An umbilical cord-derived cellular preparation offered in two strengths for flexible dosing.
Product illustration. Photos available on request. Actual packaging may differ.
A single dose of 5 million Muse cells (SSEA-3 verified) combined with 20 million umbilical cord MSCs.
Part of the biologics line. Compare all 11 products by type, format, and storageCommon in: Regenerative medicine
| Contents | 5M Muse cells + 20M UC-MSCs |
|---|
From Comprehensive Biosciences materials. Confirm current specs and IFU before use.
Biotechnology company founded in 2022 and led by Dr. Charles Sly and Dr. Roy Korth, with patented methods for isolating serum components and perinatal tissue. Its birth-tissue line comes from a manufacturer-owned, FDA-registered tissue bank: Wharton's Jelly, exosomes, Muse cell products, cord blood plasma extract, and Bio Scaffolding.
An umbilical cord-derived cellular preparation offered in two strengths for flexible dosing.
A concentrated umbilical cord Wharton's Jelly product with live cells kept in the native Wharton's Jelly matrix. For non-IV procedures only.
WJ+ with the live cells removed, keeping the growth factors, hyaluronic acid, exosomes, and ECM proteins. A cell-free option for non-IV procedures.